{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:04Z","timestamp":1791496624211,"version":"4.3.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acute lung injury (ALI) is a common complication of critical illness that could frequently lead to acute respiratory distress syndrome and other serious clinical consequences. Sepsis is one of the major and most common inducements among all causes of ALI. Due to its high incidence and mortality rate and also the complexity in treatment, sepsis-related ALI has become an urgent clinical problem waiting to be solved effectively. At present, only the protective ventilation strategy, restrictive fluid management, and antibiotics application are measures that can improve the prognosis with evidence-based medical proof. No pharmacological treatment is currently available to protect or significantly reverse the prognosis. Seeking for effective interventions measures for sepsis-related ALI is one of the most necessitous research directions. In this research, a conspicuous discovery of treatment-related translational use for a 4-benzene-indol derivative was elaborated by screening a large number of chemical compounds. The results showed that 4-benzene-indol derivative could not only suppress the activation of NLRP3 inflammasome both <jats:italic>in vitro<\/jats:italic> and alleviate LPS-induced ALI <jats:italic>in vivo<\/jats:italic> but also suppress the NLRP3 inflammasome in human myeloid leukemia mononuclear cells (THP-1) cell lines. Mechanistically, 1,2-diol blocks the NLRP3 inflammasome activation by disrupting NLRP3\u2013NEK7 interaction and the subsequent NLRP3 inflammasome assembly and activation. To summarize, this research indicated that the newly-discovered 4-benzene-indol derivative targets NLRP3 inflammasome signaling, which consequently alleviates sepsis-related ALI. Collectively, the 4-benzene-indol derivative may serve as a potential therapeutic drug and NLRP3 inflammasome signaling would be a novel pharmaceutical target for clinical treatment of sepsis-related ALI.<\/jats:p>","DOI":"10.3389\/fimmu.2022.812164","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:22:34Z","timestamp":1644481354000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome"],"prefix":"10.3389","volume":"13","author":[{"given":"Junmei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Cavagnaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415236","article-title":"Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis","volume":"372","author":"Kaukonen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/000313481207800102","article-title":"Sepsis, Systemic Inflammatory Response, and Multiple Organ Dysfunction: The Mystery Continues","volume":"78","author":"Fry","year":"2012","journal-title":"Am Surgeon"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMclde1815472","article-title":"Sepsis Guidelines","volume":"380","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccm.2006.06.010","article-title":"Why do Patients Who Have Acute Lung Injury\/Acute Respiratory Distress Syndrome Die From Multiple Organ Dysfunction Syndrome? Implications for management","volume":"27","author":"Vincent","year":"2006","journal-title":"Clinics Chest Med"},{"key":"B5","article-title":"Acute Lung Injury and the Acute Respiratory Distress Syndrome: Pathophysiology and Treatment","volume":"107","author":"Matuschak","year":"2010","journal-title":"Missouri Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","article-title":"Acute Respiratory Distress Syndrome: The Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"Jama"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute Respiratory Distress Syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.11-6-615","article-title":"Acute Lung Injury","volume":"11","author":"Parekh","year":"2011","journal-title":"Clin Med (London England)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1741","article-title":"Acute Lung Injury Review","volume":"48","author":"Tsushima","year":"2009","journal-title":"Internal Med (Tokyo Japan)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR Gene Family: A Standard Nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular Mechanism of NLRP3 Inflammasome Activation","volume":"30","author":"Jin","year":"2010","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cmi.2016.45","article-title":"Innate Immunity and Inflammation","volume":"14","author":"Xiao","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400368","article-title":"Critical Role for the NLRP3 Inflammasome During Acute Lung Injury","volume":"192","author":"Grailer","year":"2014","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12322","article-title":"Melatonin Alleviates Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome","volume":"60","author":"Zhang","year":"2016","journal-title":"J Pineal Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome Activation and Regulation: Toward a Better Understanding of Complex Mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-021-01581-1","article-title":"Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In Vitro and In Vivo","volume":"17","author":"Liu","year":"2021","journal-title":"Inflammation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00306","article-title":"Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR\/JAK2\/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice","volume":"11","author":"Cao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318180dc74","article-title":"The Impact of Development of Acute Lung Injury on Hospital Mortality in Critically Ill Trauma Patients","volume":"36","author":"Shah","year":"2008","journal-title":"Crit Care Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1976","article-title":"Epidemiology and Outcomes of Acute Lung Injury","volume":"131","author":"Rubenfeld","year":"2007","journal-title":"Chest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute Lung Injury: A Clinical and Molecular Review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2011.05.005","article-title":"Epidemiology of ARDS and ALI","volume":"27","author":"Blank","year":"2011","journal-title":"Crit Care Clinics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2476824","article-title":"Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome","volume":"2018","author":"Patel","year":"2018","journal-title":"BioMed Res Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01054","article-title":"Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome","volume":"9","author":"Shim","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00670-3","article-title":"An Update on the Regulatory Mechanisms of NLRP3 Inflammasome Activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","article-title":"The NLRP3 Inflammasome and Its Role in Sepsis Development","volume":"43","author":"Danielski","year":"2020","journal-title":"Inflammation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201905-1013OC","article-title":"Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis","volume":"200","author":"McElvaney","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/08923973.2017.1355377","article-title":"Inhibition of NLRP3 Inflammasome: A New Protective Mechanism of Cinnamaldehyde in Endotoxin Poisoning of Mice","volume":"39","author":"Xu","year":"2017","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.intimp.2014.02.017","article-title":"Hemin Inhibits NLRP3 Inflammasome Activation in Sepsis-Induced Acute Lung Injury, Involving Heme Oxygenase-1","volume":"20","author":"Luo","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-019-00990-7","article-title":"Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury Through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model","volume":"42","author":"Wang","year":"2019","journal-title":"Inflammation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent Advances in the Mechanisms of NLRP3 Inflammasome Activation and Its Inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141921","article-title":"The NLRP3\/ASC\/Caspase-1 Axis Regulates IL-1\u03b2 Processing in Neutrophils","volume":"42","author":"Mankan","year":"2012","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.812164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:22:37Z","timestamp":1644481357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.812164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2022.812164"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.812164","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"article-number":"812164"}}